# A Prospective, Multicenter, Randomized, Parallel-controlled, Superiority Trial

> **NCT07534995** · PHASE3 · NOT_YET_RECRUITING · sponsor: **First Teaching Hospital of Tianjin University of Traditional Chinese Medicine** · enrollment: 270 (estimated)

## Conditions studied

- OIC

## Interventions

- **DRUG:** the Shouhui Tongbian Capsule
- **DRUG:** Lactulose

## Key facts

- **NCT ID:** NCT07534995
- **Lead sponsor:** First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-30
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07534995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07534995, "A Prospective, Multicenter, Randomized, Parallel-controlled, Superiority Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07534995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*